DUPONT CAPITAL MANAGEMENT CORP - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 166 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$183,000
+4.0%
61,175
-8.1%
0.01%
+16.7%
Q4 2021$176,000
-71.0%
66,586
-60.2%
0.01%
-68.4%
Q3 2021$607,000
+3.8%
167,227
+24.1%
0.02%
+35.7%
Q2 2021$585,000
+26.9%
134,7240.0%0.01%
+27.3%
Q1 2021$461,000
-18.8%
134,724
-17.0%
0.01%
-8.3%
Q4 2020$568,000
+35.6%
162,353
-6.9%
0.01%
+33.3%
Q3 2020$419,000
+87.1%
174,470
+42.7%
0.01%
+80.0%
Q2 2020$224,000122,2520.01%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Tamarack Advisers, LP 4,500,000$11,925,0004.90%
HealthInvest Partners AB 1,090,000$2,889,0004.07%
GREAT POINT PARTNERS LLC 5,000,000$13,250,0002.94%
CM Management, LLC 775,000$2,054,0001.55%
SECTOR GAMMA AS 1,469,604$3,894,0000.92%
Sio Capital Management, LLC 913,621$2,421,0000.73%
Telemetry Investments, L.L.C. 190,000$504,0000.65%
DAFNA Capital Management LLC 879,000$2,329,0000.59%
Rock Springs Capital Management LP 4,860,200$12,880,0000.30%
Rhenman & Partners Asset Management AB 1,520,000$4,074,0000.27%
View complete list of RIGEL PHARMACEUTICALS INC shareholders